Completing the assessment on the Blue Haven Rx website does not establish a doctor-patient relationship between the individual and Blue Haven Rx. Beluga Health, a network of US-licensed physicians committed to rigorous medical protocols to ensure patient safety, has set exclusionary criteria to determine whether an individual is ineligible for NAD+ therapies. The responses provided in the Blue Haven Rx assessment will identify if an individual is considered excluded or non-excluded. Blue Haven Rx serves as a facilitator, connecting non-excluded individuals with Beluga Health and its clinicians. The decision to prescribe or recommend NAD+ products, including injections, face cream, and nasal spray, lies solely with Beluga Health clinicians, thereby forming the doctor-patient relationship with those seeking care.

Any claims and benefits mentioned on this website regarding NAD+ therapies are based on studies of non-compounded or research-backed formulations of NAD+. Results from compounded NAD+ products available through the Blue Haven Rx platform may vary. These compounded products are manufactured in FDA-licensed 503A Outsourcing Facilities. While these facilities are subject to stringent regulation, the compounded formulations themselves are not FDA-approved, as they are tailored to individual prescriptions for specific patients. The decision to use compounded medications is based on the licensed provider’s medical judgment, informed by a telehealth consultation and the patient’s medical history.

We strongly advise all potential users of NAD+ therapies—including injections, face creams, and nasal sprays—to discuss the particular risks and benefits of compounded products with their healthcare provider. As Blue Haven Rx is not involved in the production of these NAD+ therapies, the appearance of the products you receive may differ from what is depicted on the website.